The pro-inflammatory signaling molecule HMGB1 has attracted particular attention as a possible mechanistic biomarker for epilepsy, with studies showing that, similar to the P2X7R, drugs interfering with HMGB1 signaling provide potent anticonvulsive and antiepileptic effects [51]. Here, HMGB1 is linked to epilepsy.